Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus.

Umansky, M

Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus. [electronic resource] - Oncogene Nov 2001 - 7987-91 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0950-9232

10.1038/sj.onc.1204947 doi


Adult
Aged
Aged, 80 and over
Anti-Ulcer Agents--pharmacology
Barrett Esophagus--drug therapy
Cell Cycle--drug effects
Cyclin D1--genetics
Cyclin E--genetics
Cyclin-Dependent Kinase Inhibitor p16--genetics
Cyclin-Dependent Kinase Inhibitor p21
Cyclins--genetics
DNA, Neoplasm--analysis
Enzyme Inhibitors--pharmacology
Female
Gene Dosage
Gene Expression Regulation, Neoplastic--drug effects
Genes, Tumor Suppressor
Humans
Immunohistochemistry
Male
Middle Aged
Proliferating Cell Nuclear Antigen--genetics
Proton Pump Inhibitors
Proton Pumps--metabolism